- Home
- MOGU vs GTBP Comparison
MOGU vs GTBP Comparison
Compare MOGU & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOGU | GTBP |
|---|---|---|
| Founded | 2011 | 1965 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 17.7M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MOGU | GTBP |
|---|---|---|
| Price | $1.96 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.4K | ★ 1.3M |
| Earning Date | 01-29-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $0.26 |
| 52 Week High | $8.10 | $2.31 |
Technical Indicators
Market Signals| Indicator | MOGU | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 52.81 |
| Support Level | $1.97 | $0.39 |
| Resistance Level | $2.51 | $0.57 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 69.90 | 40.78 |
Price Performance
Historical ComparisonAbout MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.